Tuberculosis drug resistance in Canada: 2018
Background: Drug-resistant tuberculosis (TB) is a public health issue of global importance that poses a threat to TB control efforts. Canada conducts nationwide surveillance to monitor emerging drug resistance trends and document progress towards reaching the goal of TB elimination. Objective: To de...
Published in: | Canada Communicable Disease Report |
---|---|
Main Authors: | , , , |
Format: | Article in Journal/Newspaper |
Language: | English French |
Published: |
Public Health Agency of Canada
2020
|
Subjects: | |
Online Access: | https://doi.org/10.14745/ccdr.v46i01a02 https://doaj.org/article/c304b923282a4c10bddd60f884135f86 |
id |
ftdoajarticles:oai:doaj.org/article:c304b923282a4c10bddd60f884135f86 |
---|---|
record_format |
openpolar |
spelling |
ftdoajarticles:oai:doaj.org/article:c304b923282a4c10bddd60f884135f86 2023-05-15T17:46:46+02:00 Tuberculosis drug resistance in Canada: 2018 Marie LaFreniere Demy Dam Lori Strudwick Sarah McDermott 2020-01-01T00:00:00Z https://doi.org/10.14745/ccdr.v46i01a02 https://doaj.org/article/c304b923282a4c10bddd60f884135f86 EN FR eng fre Public Health Agency of Canada https://doi.org/10.14745/ccdr.v46i01a02 https://doaj.org/toc/1481-8531 doi:10.14745/ccdr.v46i01a02 1481-8531 https://doaj.org/article/c304b923282a4c10bddd60f884135f86 Canada Communicable Disease Report, Vol 46, Iss 1, Pp 9-15 (2020) tuberculosis surveillance drug resistance canada Infectious and parasitic diseases RC109-216 article 2020 ftdoajarticles https://doi.org/10.14745/ccdr.v46i01a02 2022-12-31T08:13:33Z Background: Drug-resistant tuberculosis (TB) is a public health issue of global importance that poses a threat to TB control efforts. Canada conducts nationwide surveillance to monitor emerging drug resistance trends and document progress towards reaching the goal of TB elimination. Objective: To describe TB drug resistance trends across Canada from 2008–2018, with a focus on 2018, by drug resistance, geographic and demographic patterns. Methods: TB drug resistance data are captured through two independent surveillance systems managed by the Public Health Agency of Canada: Canadian Tuberculosis Laboratory Surveillance System (CTBLSS) and the Canadian Tuberculosis Reporting System (CTBRS). Data from these systems were analyzed and descriptive statistics were reported by resistance profile, place of residence (province), age groups, sex and country of birth. Results: In 2018, 1,459 TB isolates underwent drug susceptibility testing, a 4.3% decrease from 2017. Resistance to any first-line drug was reported in 148 isolates (10.1%), compared to 123 (8.1%) in 2017. Of these, 121 were monoresistant, five were polyresistant, 21 were multidrug-resistant tuberculosis (MDR-TB) and one was extensively drug-resistant TB (XDR-TB). Drug resistance was reported in all provinces and territories except Prince Edward Island, Northwest Territories and Yukon. Among individuals younger than 15 years, very little TB drug resistance was detected. Among individuals aged 15 years and older, the distribution of TB drug resistance varied with no discernable trends. The proportion of drug resistance was slightly higher in females than in males. By origin, 10.7% of foreign-born TB cases reported between 2006 and 2016 were drug-resistant. Among the Canadian-born non-Indigenous cases, 9.3% were drug resistant; among Canadian-born Indigenous, 2.4% were drug resistant. Conclusion: In 2018, the proportion of isolates with TB drug resistance in Canada remained low and below global averages, with stable drug resistance, both geographically and ... Article in Journal/Newspaper Northwest Territories Prince Edward Island Yukon Directory of Open Access Journals: DOAJ Articles Yukon Northwest Territories Canada Canada Communicable Disease Report 46 01 9 15 |
institution |
Open Polar |
collection |
Directory of Open Access Journals: DOAJ Articles |
op_collection_id |
ftdoajarticles |
language |
English French |
topic |
tuberculosis surveillance drug resistance canada Infectious and parasitic diseases RC109-216 |
spellingShingle |
tuberculosis surveillance drug resistance canada Infectious and parasitic diseases RC109-216 Marie LaFreniere Demy Dam Lori Strudwick Sarah McDermott Tuberculosis drug resistance in Canada: 2018 |
topic_facet |
tuberculosis surveillance drug resistance canada Infectious and parasitic diseases RC109-216 |
description |
Background: Drug-resistant tuberculosis (TB) is a public health issue of global importance that poses a threat to TB control efforts. Canada conducts nationwide surveillance to monitor emerging drug resistance trends and document progress towards reaching the goal of TB elimination. Objective: To describe TB drug resistance trends across Canada from 2008–2018, with a focus on 2018, by drug resistance, geographic and demographic patterns. Methods: TB drug resistance data are captured through two independent surveillance systems managed by the Public Health Agency of Canada: Canadian Tuberculosis Laboratory Surveillance System (CTBLSS) and the Canadian Tuberculosis Reporting System (CTBRS). Data from these systems were analyzed and descriptive statistics were reported by resistance profile, place of residence (province), age groups, sex and country of birth. Results: In 2018, 1,459 TB isolates underwent drug susceptibility testing, a 4.3% decrease from 2017. Resistance to any first-line drug was reported in 148 isolates (10.1%), compared to 123 (8.1%) in 2017. Of these, 121 were monoresistant, five were polyresistant, 21 were multidrug-resistant tuberculosis (MDR-TB) and one was extensively drug-resistant TB (XDR-TB). Drug resistance was reported in all provinces and territories except Prince Edward Island, Northwest Territories and Yukon. Among individuals younger than 15 years, very little TB drug resistance was detected. Among individuals aged 15 years and older, the distribution of TB drug resistance varied with no discernable trends. The proportion of drug resistance was slightly higher in females than in males. By origin, 10.7% of foreign-born TB cases reported between 2006 and 2016 were drug-resistant. Among the Canadian-born non-Indigenous cases, 9.3% were drug resistant; among Canadian-born Indigenous, 2.4% were drug resistant. Conclusion: In 2018, the proportion of isolates with TB drug resistance in Canada remained low and below global averages, with stable drug resistance, both geographically and ... |
format |
Article in Journal/Newspaper |
author |
Marie LaFreniere Demy Dam Lori Strudwick Sarah McDermott |
author_facet |
Marie LaFreniere Demy Dam Lori Strudwick Sarah McDermott |
author_sort |
Marie LaFreniere |
title |
Tuberculosis drug resistance in Canada: 2018 |
title_short |
Tuberculosis drug resistance in Canada: 2018 |
title_full |
Tuberculosis drug resistance in Canada: 2018 |
title_fullStr |
Tuberculosis drug resistance in Canada: 2018 |
title_full_unstemmed |
Tuberculosis drug resistance in Canada: 2018 |
title_sort |
tuberculosis drug resistance in canada: 2018 |
publisher |
Public Health Agency of Canada |
publishDate |
2020 |
url |
https://doi.org/10.14745/ccdr.v46i01a02 https://doaj.org/article/c304b923282a4c10bddd60f884135f86 |
geographic |
Yukon Northwest Territories Canada |
geographic_facet |
Yukon Northwest Territories Canada |
genre |
Northwest Territories Prince Edward Island Yukon |
genre_facet |
Northwest Territories Prince Edward Island Yukon |
op_source |
Canada Communicable Disease Report, Vol 46, Iss 1, Pp 9-15 (2020) |
op_relation |
https://doi.org/10.14745/ccdr.v46i01a02 https://doaj.org/toc/1481-8531 doi:10.14745/ccdr.v46i01a02 1481-8531 https://doaj.org/article/c304b923282a4c10bddd60f884135f86 |
op_doi |
https://doi.org/10.14745/ccdr.v46i01a02 |
container_title |
Canada Communicable Disease Report |
container_volume |
46 |
container_issue |
01 |
container_start_page |
9 |
op_container_end_page |
15 |
_version_ |
1766150602131243008 |